ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

MXCT Maxcyte Inc

370.00
0.00 (0.00%)
31 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Maxcyte Inc MXCT London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 370.00 02:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
370.00 370.00 370.00 370.00 370.00
más cotizaciones de acciones »
Sector Industrial de la empresa
PHARMACEUTICALS & BIOTECHNOLOGY

Noticias Recientes

Fecha Hora Fuente Noticia
29/5/202407:05UK RNSMaxCyte, Inc. Participation in Upcoming Investor Conference
29/5/202407:05GLOBEMaxCyte to Participate in William Blair 44th Annual Growth..
22/5/202415:51ALNCNewsIN BRIEF: MaxCyte inks deal with Legend Biotech for tech..
22/5/202407:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
22/5/202407:05GLOBEMaxCyte Signs Strategic Platform License Agreement with..
20/5/202401:00UK RNSMaxCyte, Inc. Holding(s) in Company
14/5/202408:55UK RNSMaxCyte, Inc. Holding(s) in Company
08/5/202403:46ALNCNewsMaxCyte shares rise amid double-digit revenue increase
08/5/202401:05UK RNSMaxCyte, Inc. Filing of Form 10-Q
08/5/202401:00UK RNSMaxCyte, Inc. First Quarter Results
07/5/202415:05GLOBEMaxCyte Reports First Quarter 2024 Financial Results and..
03/5/202401:00UK RNSMaxCyte, Inc. Notice of AGM
01/5/202411:04UK RNSMaxCyte, Inc. Total Voting Rights
10/4/202407:05UK RNSMaxCyte, Inc. Notice of Results
10/4/202407:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
03/4/202401:00UK RNSMaxCyte, Inc. Total Voting Rights and Block Listing Return
02/4/202409:19ALNCNewsTRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian..
02/4/202407:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
02/4/202407:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
02/4/202401:00UK RNSMaxCyte, Inc. Exercise of options and PDMR dealing
20/3/202405:16UK RNSMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR..
20/3/202405:05UK RNSMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR..
13/3/202406:54ALNCNewsIN BRIEF: MaxCyte loss widens in 2023 as core revenue..
13/3/202402:05UK RNSMaxCyte, Inc. Filing of form 10-K for FY ended December 31,..
13/3/202402:00UK RNSMaxCyte, Inc. Reports Q4 & FY 2023 Financial Results
12/3/202415:05UKREGMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202402:58UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
05/3/202414:43ALNCNewsEARNINGS: dotdigital eyes rosy future; Beeks Financial turns..
05/3/202401:00UK RNSMaxCyte, Inc. Preliminary FY Results & 2024 Guidance
04/3/202415:05UKREGMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
01/3/202411:57UK RNSMaxCyte, Inc. Total Voting Rights
29/2/202403:21UK RNSMaxCyte, Inc. Exercise of options and PDMR dealing
26/2/202401:00UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
09/2/202407:05UK RNSMaxCyte, Inc. Notice of Results
09/2/202407:05UKREGMaxCyte to Report Fourth Quarter and Full Year 2023..
01/2/202403:24UK RNSMaxCyte, Inc. Total Voting Rights
31/1/202401:00UK RNSMaxCyte, Inc. Director/PDMR Shareholding
30/1/202408:29UK RNSMaxCyte, Inc. Holding(s) in Company
30/1/202407:58ALNCNewsIN BRIEF: MaxCyte signs licencing deal with cell therapy..
30/1/202407:05UK RNSMaxCyte, Inc. Signing of Strategic Platform License
30/1/202407:05UKREGMaxCyte and Wugen Sign Strategic Platform License to..
29/1/202411:56ALNCNewsIN BRIEF: MaxCyte chief scientific officer leaves firm
29/1/202410:52UK RNSMaxCyte, Inc. TR-1: Notification of major holdings
29/1/202401:00UK RNSMaxCyte, Inc. Filing of Form 8-K
23/1/202412:39ALNCNewsTRADING UPDATES: Esken's Southend Airport faces further..
23/1/202407:05GLOBEMaxCyte Signs Strategic Platform License with Imugene to..
23/1/202407:05UKREGMaxCyte, Inc. Signing of Strategic Platform License
09/1/202406:18ALNCNewsMaxCyte's strategic platform licences redeem otherwise..
09/1/202401:00UKREGMaxCyte, Inc. Preliminary Unaudited Q4 and FY 2023 Results
08/1/202415:05GLOBEMaxCyte Announces Preliminary Unaudited Fourth Quarter and..

Su Consulta Reciente

Delayed Upgrade Clock